Literature DB >> 15073494

The importance of family history on the development of renal disease.

Scott G Satko1, Barry I Freedman.   

Abstract

PURPOSE OF REVIEW: Family history of end-stage renal disease is an important risk factor for the subsequent development of nephropathy. Multiply-affected families with members demonstrating end-stage renal disease often contain individuals with disparate etiologies of renal disease. These observations have led to the search for nephropathy susceptibility genes. RECENT
FINDINGS: Genetic loci associated with susceptibility to diabetic (3q, 18q22.3-23) and non-diabetic nephropathy (chromosome 10) have been identified. A mutation in the uromodulin gene (16p11-13) has recently been linked to medullary cystic kidney disease type 2 and familial juvenile hyperuricemic nephropathy. Familial focal segmental glomerulosclerosis is linked to the 1q25-31, 11q21-22, and 19q13 loci in different families. Several research groups are evaluating family members of individuals with nephropathy in an attempt to uncover previously undiagnosed cases of renal disease.
SUMMARY: Family members of individuals with chronic kidney disease are disproportionately affected with unrecognized and asymptomatic nephropathy. Screening of these high-risk relatives for early nephropathy, and for risk factors for nephropathy, will probably lead to successful treatment for nephropathy and slow the growing worldwide epidemic of end-stage renal disease.

Entities:  

Mesh:

Year:  2004        PMID: 15073494     DOI: 10.1097/00041552-200405000-00012

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  8 in total

1.  TGF-alpha mediates genetic susceptibility to chronic kidney disease.

Authors:  Denise Laouari; Martine Burtin; Aurélie Phelep; Carla Martino; Evangeline Pillebout; Xavier Montagutelli; Gérard Friedlander; Fabiola Terzi
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

Review 2.  Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications.

Authors:  José M López-Novoa; Ana B Rodríguez-Peña; Alberto Ortiz; Carlos Martínez-Salgado; Francisco J López Hernández
Journal:  J Transl Med       Date:  2011-01-20       Impact factor: 5.531

3.  Dietary protein intake and renal function.

Authors:  William F Martin; Lawrence E Armstrong; Nancy R Rodriguez
Journal:  Nutr Metab (Lond)       Date:  2005-09-20       Impact factor: 4.169

Review 4.  Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN).

Authors:  Xiqian Lan; T K S Rao; Praveen N Chander; Karl Skorecki; Pravin C Singhal
Journal:  Front Microbiol       Date:  2015-06-09       Impact factor: 5.640

5.  Familial risks of kidney failure in Sweden: a nationwide family study.

Authors:  Delshad Saleh Akrawi; Xinjun Li; Jan Sundquist; Kristina Sundquist; Bengt Zöller
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

6.  Genetic variation underlying renal uric acid excretion in Hispanic children: the Viva La Familia Study.

Authors:  Geetha Chittoor; Karin Haack; Nitesh R Mehta; Sandra Laston; Shelley A Cole; Anthony G Comuzzie; Nancy F Butte; V Saroja Voruganti
Journal:  BMC Med Genet       Date:  2017-01-17       Impact factor: 2.103

7.  Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study.

Authors:  Audrey Y Chu; Rulan S Parekh; Brad C Astor; Josef Coresh; Yvette Berthier-Schaad; Michael W Smith; Alan R Shuldiner; Wen Hong L Kao
Journal:  BMC Med Genet       Date:  2009-10-23       Impact factor: 2.103

8.  Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China.

Authors:  Xianglei Kong; Li Liu; Li Zuo; Ping Yuan; Zhongxin Li; Wenge Li; Meishun Cai; Xiangmei Chen; Aili Jiang; Gang Long; Jinsheng Xu; Hongli Lin; Shixiang Wang; Wen Huang; Yiping Wang; Yidan Guo; Po Cao; Hua Wu; Qiang Jia; Luxia Zhang; Mei Wang; Haiyan Wang
Journal:  BMC Nephrol       Date:  2013-01-18       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.